Assignee
LIPOXEN TECH LIMITED
GB·9 granted patents·8 pending applications·0 citations·filing 2015–2022
Top patents by PatentIndex Score
17 records- 0174US2022133898A1Derivatisation of Insulin with PolysaccharidesLIPOXEN TECH LIMITED·Filed 2022·Application pending·0 cites
- 0273US10494449B2Fractionation of charged polysaccharideLIPOXEN TECH LIMITED·Filed 2017·Granted Dec 3, 2019·0 cites·5 claims
- 0367US10155046B2Activated sialic acid derivatives for protein derivatisation and conjugationLIPOXEN TECH LIMITED·Filed 2015·Granted Dec 18, 2018·0 cites·35 claims
- 0466US10301396B2Reduction of endotoxin in polysialic acidsLIPOXEN TECH LIMITED·Filed 2015·Granted May 28, 2019·0 cites·25 claims
- 0566US2021401999A1Methods of treating diseases related to net formation with parenteral administration of polysialylated dnase iLIPOXEN TECH LIMITED·Filed 2021·Application pending·0 cites
- 0666US2019216938A1Derivatisation of Insulin with PolysaccharidesLIPOXEN TECH LIMITED·Filed 2019·Application pending·0 cites
- 0765US10155045B2Activated sialic acid derivatives for protein derivatisation and conjugationLIPOXEN TECH LIMITED·Filed 2015·Granted Dec 18, 2018·0 cites·49 claims
- 0865US9920137B2Polysialic acid derivativesLIPOXEN TECH LIMITED·Filed 2015·Granted Mar 20, 2018·0 cites·14 claims
- 0965US2022008544A1Methods of treating multiple myeloma cancers expressing high levels of epo-receptor using psa-epoLIPOXEN TECH LIMITED·Filed 2021·Application pending·0 cites
- 1063US10772968B2Glycopolysialylation of non-blood coagulation proteinsLIPOXEN TECH LIMITED·Filed 2017·Granted Sep 15, 2020·0 cites·2 claims
- 1162US9828443B2Fractionation of charged polysaccharideLIPOXEN TECH LIMITED·Filed 2015·Granted Nov 28, 2017·0 cites·34 claims
- 1262US2018289823A1N-Terminal PolysialylationLIPOXEN TECH LIMITED·Filed 2017·Application pending·0 cites
- 1359US2019083636A1Methods of treating diseases related to net formation with parenteral administration of polysialylated dnase iLIPOXEN TECH LIMITED·Filed 2018·Application pending·0 cites
- 1458US10406209B2Sialic acid derivatives for protein derivatisation and conjugationLIPOXEN TECH LIMITED·Filed 2016·Granted Sep 10, 2019·0 cites·6 claims
- 1550US2020179524A1Methods of treating multiple myeloma cancers expressing high levels of epo-receptor using psa-epoLIPOXEN TECH LIMITED·Filed 2018·Application pending·0 cites
- 1646US2022023430A1Glycopolysialylation of blinatumomabLIPOXEN TECH LIMITED·Filed 2019·Application pending·0 cites
- 1745US10406150B2Method for treatment of primary hormone resistant endometrial and breast cancersLIPOXEN TECH LIMITED·Filed 2017·Granted Sep 10, 2019·0 cites·13 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →